Embio Limited has secured an investment from True North, pursuant to which the investor has acquired a minority stake in the company.
Khaitan & Co advised Embio on all legal aspects of the transaction.
The transaction was led by Bhavik Narsana (Partner), with support from Ipshita Dey (Senior Associate), Associates Kamayani Mittal, Pragya Mishra and Sakshi Mehta.
Legal Due Diligence (Legal DD): Bhavik Narsana (Partner), Shweta Dwivedi (Consultant), Associates Kamayani Mittal and Pragya Mishra.
Employment for Legal DD: Deepak Kumar (Partner) and Ananya Gandhi (Associate).
Intellectual Property for Legal DD: Shailendra Bhandare (Partner), Janaksinh Jhala (Counsel), Abhishek Kumar (Principal Associate), Vaishali Adhikari (Senior Associate) and Shouraseni Chakraborty (Associate).
Real Estate for Legal DD: Amit Wadhwani (Partner), Mudit Shah (Partner), Pavithra Thammaiah (Partner), Shrey Bheda (Principal Associate), Associates Hanumant Chauhan, Nidhi Marakana and Esha Sanjyot Shah.
Litigation for Legal DD: Raj R. Panchmatia (Partner), Peshwan Jehangir (Partner), Divya Chaturvedi (Partner), Srishti Rai (Counsel), Ayush Jain (Senior Associate), Niyathi Kalra (Senior Associate), Chandan Kumar (Associate).
Cyril Amarchand Mangaldas advised True North on this transaction.
The transaction team was led by Aditi Manchanda (Partner) and Abhishek Kalra (Partner), with support from Naimi Kamdar (Principal Associate), Chandni Ochani (Principal Associate), and Rajat Pareek (Associate). The core transaction team was supported by Kaushik Raichura (Senior Associate) on due diligence aspects.
Biplab Lenin (Partner), with support from Anam Chowdhary (Associate), assisted on pharma and healthcare due diligence and related aspects for the transaction.
Arya Tripathy (Partner), with support from Milind Yadav (Associate), assisted on intellectual property, information technology, and data privacy due diligence and related aspects.
Sowmya Kumar (Partner), with support from Luv Saggi (Director – Employment) and Tara Thakur (Associate), assisted on employment due diligence and related aspects.
Dhruv Rajain (Partner), with support from Ridhima Sethi (Associate), assisted on CCI analysis.
Siddharth Singh (Partner), with support from Rushi Panchal (Associate), assisted on real estate-related aspects.
Embio specializes in the manufacturing of complex, high value APIs and advanced intermediates with deep expertise in synthetic biology and precision fermentation. The Company has established a leadership position in controlled substances across several therapeutic areas, including nasal decongestants, ADHD, Parkinson’s diseases, anti-epileptics, among others.
The proceeds from this investment will fuel Embio’s next phase of growth through investments in R&D, talent acquisition, capacity expansion at its Dahej facility, and the scaling of its CDMO business.
If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.